Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must weigh at least 36 pounds (16 kilograms)~* patients must have partial onset seizures (with or without secondarily generalized seizures) being treated with at least one, but no more than two antiepileptic drugs (AEDs)~* patients must have at least 6 partial onset seizures during the 8-week baseline phase, with at least one seizure during each 4-week period~* an electroencephalogram (EEG) with features consistent with partial epilepsy performed prior to study initiation or during the baseline phase~Exclusion Criteria:~* Females who are pregnant, nursing, or those not using adequate birth control if capable of having children~* patients with a treatable cause of seizures (for example, infections)~* patients with a progressive disorder of the nervous system~* patients with a clinical diagnosis of Lennox-Gastaut syndrome~* patients with a history of generalized status epilepticus (repeated or prolonged seizures) while on appropriate anti-epileptic therapy

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 16 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).